Products & ReviewDrug Discovery & Development
Neoantigen Peptide Synthesis Service
GenScript’s Neoantigen Peptide Synthesis Service supports everything from functional screening of neoantigen candidates for TCR therapy to clinical stage vaccine immunogenicity testing.
Neoantigen peptides are usually expressed on the cell surface, and arise due to single amino acid deletions, insertions, or substitutions. Because of this, they vary in length, charge, and hydrophobicity, leading to difficulty in synthesis and purification. With over 20 years experience, GenScript delivers reliable and quality peptides with over 95% success rate and duperior immunogenicity.